Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

RTP to accelerate development of insoluble drug delivery technology

Dec. 5, 1996

Incyte and Abbott expand genomic database agreement

Dec. 5, 1996

Patent issued for Vical's core technology

Dec. 5, 1996

Neurochem/Parke-Davis collaboration on antiamyloid compounds

Dec. 4, 1996

Forbes Medi-Tech awarded research grant

Dec. 4, 1996

BMS-Aurora research agreement on screening technology

Dec. 4, 1996

Zeneca and Rutgers collaborate on apoptosis research

Dec. 4, 1996

Incyte-Affymetrix to develop and commercialize new chip-based genomic databases

Dec. 2, 1996

Expanded patent portfolio for Dyax technology

Dec. 2, 1996

Methods for screening for neurotoxicity offered for licensing

Dec. 2, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...